These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 3048310)

  • 1. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-proliferative effects of tumor necrosis factor and gamma interferon on human ovarian cancer cell lines].
    Li J; Liu YL; Sha JY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):670-2, 700. PubMed ID: 7712890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
    Yasui H; Adachi M; Imai K
    Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
    van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
    Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated recombinant human tumor necrosis factor alpha: preparation and anti-tumor potency.
    Li YP; Pei YY; Ding J; Shen ZM; Zhang XY; Gu ZH; Zhou JJ
    Acta Pharmacol Sin; 2001 Jun; 22(6):549-55. PubMed ID: 11747763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-cancer activity of tumour necrosis factor.
    Malik S; Balkwill F
    Ann Inst Pasteur Immunol; 1988; 139(3):285-8. PubMed ID: 3048310
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour necrosis factor.
    Gifford GE; Flick DA
    Microbiol Sci; 1988 Apr; 5(4):104-7. PubMed ID: 3152764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor necrosis factor-alpha--biological and immunologic properties].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):392-5. PubMed ID: 9424334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
    Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
    Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple facets of induction of tumour necrosis.
    Bloksma N; van de Wiel PA; Kuper CF; Hofhuis FM
    Ann Inst Pasteur Immunol; 1988; 139(3):294-9. PubMed ID: 3048312
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF: a brief review with emphasis on its antitumor activity.
    Scheringa M; Marquet RL
    Biotherapy; 1990; 2(3):275-81. PubMed ID: 2206776
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.